SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001068238-23-000067
Filing Date
2023-03-22
Accepted
2023-03-22 11:13:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 CARISMA SCHEDULE 13D/A carisma_sch_13da.htm SC 13D/A 43562
  Complete submission text file 0001068238-23-000067.txt   45255
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87951 | Film No.: 23751853
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018
Business Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018 41 21 614 3500
HealthCap VII, L.P. (Filed by) CIK: 0001645161 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A